← Back to Portfolio

Vera Therapeutics

Vera is developing Atacicept, a first and best-in-class antibody to treat IgA Nephropathy (IgAN), a rare auto-immune disease. IgAN is the most common cause of kidney disease after hypertension and diabetes. Vera in-licensed Atacicept from EMD Serono, with compelling Ph 2a data.

LocationSouth San Francisco, CA
CEOMarshall Fordyce
Partner Kurt von Emster
Websitewww.veratx.com